These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6236941)

  • 1. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlative aspects of spirographic, oximetric and zonal ventilation-perfusion ratio findings in chronic obstructive bronchopneumopathy. I. Some comparative oximetric and ventilatory data in evaluation of the effectiveness of bronchodilator treatment].
    Fica V; Stănescu L; Olteanu D; Mătrescu F; Andronescu D; Ionescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(2):149-56. PubMed ID: 17907
    [No Abstract]   [Full Text] [Related]  

  • 4. Categorisation of ventilatory pattern of response to bronchodilator therapy in airflow limitation.
    Meenakshi S
    J Assoc Physicians India; 1995 Mar; 43(3):179-81. PubMed ID: 11256903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of extension of the tube in inhalers on the efficiency of bronchodilators].
    Rebić P; Radosavljević G; Jovanović D
    Plucne Bolesti; 1987; 39(3-4):226-30. PubMed ID: 3454023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Spirographic evaluation of obstructive ventilation disorders].
    Schindl R; Mayer K; Aigner K
    Wien Med Wochenschr; 1975 Jul; 125(28-31):449-52. PubMed ID: 1220301
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchial pharmacology.
    Orie NG
    Bull Physiopathol Respir (Nancy); 1972; 8(3):725-6. PubMed ID: 4645581
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between airway resistance FEV 1.0 and viscous work of breathing in patients with chronic obstructive lung disease before and after bronchodilation.
    Quanjer PH; Hilvering C; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1971; 7(3):539-54. PubMed ID: 5119274
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)].
    Sprung J
    Plucne Bolesti Tuberk; 1981; 33(1):8-13. PubMed ID: 7244024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-functional evaluation of chronic obstructive lung diseases in association with hypertension].
    Soldatchenko SS; Kononenko IN; Rudieva NB; P'iankov AF
    Vrach Delo; 1991 Jun; (6):42-3. PubMed ID: 1891848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol.
    Saleeby PR; Ziskind MM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
    Chatterjee SS; Dinda P; Riding WD
    Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of the broncho-relaxing action of a new sympathicomimetic drug on twenty patients with chronic obstructive lung disease (author's transl)].
    Sergysels R; Leblanc G; Payfa M; Hennebert A
    Acta Tuberc Pneumol Belg; 1973; 64(1):80-8. PubMed ID: 4768064
    [No Abstract]   [Full Text] [Related]  

  • 16. ["CO-diffusion capacity" and blood gases in obstructive airway diseases and their behavior under bronchodilator therapy].
    Siemon G; Thoma R; Keller R
    Verh Dtsch Ges Inn Med; 1974; 80():906-8. PubMed ID: 4454686
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary-function testing in the evaluation of bronchodilator agents.
    Menendez R; Kelly HW
    Clin Pharm; 1983; 2(2):120-8. PubMed ID: 6349904
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

  • 19. Postural drainage effect after bronchodilator inhalation in patients with chronic airway obstruction.
    Maloney FP; Fernandez E; Hudgel DW
    Arch Phys Med Rehabil; 1981 Sep; 62(9):452-5. PubMed ID: 7283688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of reproterol in patients with obstructive pathology of the airways].
    Puzio E; Montanero F; Mosca L; Caserta L; Russo V
    Clin Ter; 1985 Jan; 112(2):141-4. PubMed ID: 3893858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.